Moltek A.Ş has been established in 2007 and launched radiopharmacutical production in 2009. Moltek is a pioneer in nuclear medicine market in Turkey. Its product range has been expanding regarding necessities of the market. Moltek delivers best quality of products and services by utilizing advanced technologies and expert staff in their field. For that matter, Moltek aims to be world's leading brand. Moltek produces radiopharmaceuticals, which compromise internatioanal standards, used for diagnosis and treatment. It provides reliable and high quality service by using Good Manufacturing Practice (GMP). With new investments and enterprises, Moltek is prepared for being globally known manufacturer.
View Top Employees from Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş.Website | http://www.moltek.com.tr/ |
Revenue | $5 million |
Employees | 61 (45 on RocketReach) |
Founded | 2007 |
Phone | +90 262 677 11 60 |
Fax | +90 262 677 11 64 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Industrial Machinery & Equipment, Manufacturing |
SIC | SIC Code 58 Companies, SIC Code 581 Companies |
NAICS | NAICS Code 72251 Companies, NAICS Code 7225 Companies, NAICS Code 72 Companies, NAICS Code 722513 Companies, NAICS Code 722 Companies |
Looking for a particular Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş. employee's phone or email?
The Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş. annual revenue was $5 million in 2024.
Levent Gumussoy is the CFO of Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş..
45 people are employed at Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş..
The NAICS codes for Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş. are [72251, 7225, 72, 722513, 722].
The SIC codes for Moltek Sağlık Hizmetleri Üretim ve Pazarlama A.Ş. are [58, 581].